BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 14661127)

  • 41. Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay.
    Cheung HM; Law C; Shoichet M; Karanicolas PJ; Coburn N; Milot L
    Can Assoc Radiol J; 2016 Aug; 67(3):242-9. PubMed ID: 27318891
    [No Abstract]   [Full Text] [Related]  

  • 42. Contrast-enhanced ultrasound in the detection and characterization of liver tumors.
    Jang HJ; Yu H; Kim TK
    Cancer Imaging; 2009 Nov; 9(1):96-103. PubMed ID: 19933022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholangiocarcinoma at the hepatic hilus: sonographic findings.
    Hann LE; Greatrex KV; Bach AM; Fong Y; Blumgart LH
    AJR Am J Roentgenol; 1997 Apr; 168(4):985-9. PubMed ID: 9124155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F
    J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The ins and outs of liver imaging.
    O'Neill EK; Cogley JR; Miller FH
    Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Doppler and color Doppler ultrasound diagnosis in differentiation of focal liver lesions].
    Paintner A; Bayer C; Böttcher B; Wenk H; Swobodnik W
    Bildgebung; 1996 Mar; 63(1):22-6. PubMed ID: 8653004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Color-coded Doppler sonography of primary and secondary liver tumors].
    Börner N; Clement T; Herzog P; Kreitner KF; Miltenberger H; Schild H; Meyer J
    Ultraschall Med; 1990 Dec; 11(6):274-80. PubMed ID: 1965059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasound of focal hepatic lesions.
    Nisenbaum HL; Rowling SE
    Semin Roentgenol; 1995 Oct; 30(4):324-46. PubMed ID: 8539643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benign focal liver lesions masquerading as primary liver cancers on MRI.
    Subramanian M; Low HM; Kim MJ; Tan CH
    Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benign liver masses: imaging with microbubble contrast agents.
    Kim TK; Jang HJ; Wilson SR
    Ultrasound Q; 2006 Mar; 22(1):31-9. PubMed ID: 16641791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
    Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
    Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2001; 11 Suppl 3():E27-34. PubMed ID: 11793050
    [No Abstract]   [Full Text] [Related]  

  • 54. Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography.
    Xu HX; Chen LD; Xie XY; Xie XH; Xu ZF; Liu GJ; Lin MX; Wang Z; Lu MD
    Eur J Radiol; 2010 Aug; 75(2):197-202. PubMed ID: 19464836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of color Doppler ultrasound in preoperative planning of the resection of liver tumors].
    Bunk A; Stoelben E; Köhler T; Nagel M; Seager HD
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():428-30. PubMed ID: 9574172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
    Oldenburg A; Albrecht T
    Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.
    Jung EM; Ross CJ; Rennert J; Scherer MN; Farkas S; von Breitenbuch P; Schnitzbauer AA; Piso P; Lamby P; Menzel C; Schreyer AG; Feuerbach S; Schlitt HJ; Loss M
    Clin Hemorheol Microcirc; 2010; 46(2-3):89-99. PubMed ID: 21135485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative diagnostic value of computed tomography and contrast-enhanced ultrasonography in diagnosis of focal liver lesions].
    Zviniene K; Zaboriene I; Basevicius A; Pundzius J
    Medicina (Kaunas); 2009; 45(10):751-63. PubMed ID: 19996661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.